Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Albert HAGEGE"'
Autor:
Antoine Dusonchet, Olivier Varenne, Tania Puscas, Malika Saadi, Albert Hagege, David Calvet, Jean‐Louis Mas, Guillaume Turc
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background Patent foramen ovale (PFO) is causally associated with stroke in some patients younger than 60 years, especially when it is large or associated with an atrial septal aneurysm (ASA). After 60 years of age, this association is less well unde
Externí odkaz:
https://doaj.org/article/374688df9dc045b588b429c5450c7673
Autor:
Faouzi Addad, Abdallah Mahdhaoui, Jeridi Gouider, Essia Boughzela, Samir Kamoun, Mohamed Rachid Boujnah, Habib Haouala, Habib Gamra, Faouzi Maatouk, Ali Ben Khalfallah, Salem Kachboura, Hedi Baccar, Nejeh Ben Halima, Ali Guesmi, Khaled Sayahi, Wissem Sdiri, Ali Neji, Ahmed Bouakez, Sami Milouchi, Kais Battikh, Yves Jullieres, Nicolas Danchin, Jean Jacques Monsuez, Genevieve Mulak, Albert Hagege, Vincent Bataille, Rafik Chettaoui, Mohamed Sami Mourali, FAST-MI Tunisia investigators
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0207979 (2019)
BackgroundThe FAST-MI Tunisia registry was set up by the Tunisian Society of Cardiology and Cardiovascular Surgery to assess the demographic and clinical characteristics, management and hospital outcome of patients with ST-elevation myocardial infarc
Externí odkaz:
https://doaj.org/article/b77a89a85c91440f83394cc97af55cc6
Autor:
Maëlle Perrocheau, Soto Romuald Kiando, Déwi Vernerey, Christian Dina, Pilar Galan, Albert Hagege, Xavier Jeunemaitre, Nabila Bouatia-Naji
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 2, Iss 3, Pp 176-189 (2015)
Non-syndromic mitral valve prolapse (MVP) is a common degenerative valvulopathy, predisposing to arrhythmia and sudden death. The etiology of MVP is suspected to be under genetic control, as supported by familial cases and its manifestation in geneti
Externí odkaz:
https://doaj.org/article/879c4807144b406aaa9f772e8fd63b5c
Autor:
Giuseppe Pinto, Mauro Chiarito, Anne Bacher, Tania Puscas, Gianluigi Condorelli, Patricia Reant, Erwan Donal, Albert Hagege
Publikováno v:
European Heart Journal Supplements. 24
Background Guidelines recommend betablockers (BB) as first line therapy in symptomatic patients with hypertrophic cardiomyopathy (HCM). A secondary role in the therapeutic algorithm is assigned to non-dihydropyridine calcium channel blockers (ND-CCB)
Autor:
Maurizio, Pieroni, James C, Moon, Eloisa, Arbustini, Roberto, Barriales-Villa, Antonia, Camporeale, Andreja Cokan, Vujkovac, Perry M, Elliott, Albert, Hagege, Johanna, Kuusisto, Aleš, Linhart, Peter, Nordbeck, Iacopo, Olivotto, Päivi, Pietilä-Effati, Mehdi, Namdar
Publikováno v:
Journal of the American College of Cardiology. 77(7)
Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide (Gb3) in affected tissues, including the heart. Cardiovascular involvemen
Autor:
Louis Pechmajou, Eloi Marijon, Olivier Varenne, Florence Dumas, Frankie Beganton, Daniel Jost, Lionel Lamhaut, Eric Lecarpentier, Thomas Loeb, Jean-Marc Agostinucci, Georgios Sideris, Elisabeth Riant, Pierre Baudinaud, Albert Hagege, Wulfran Bougouin, Christian Spaulding, Alain Cariou, Xavier Jouven, Nicole Karam, F Adnet, V Algalarrondo, F Alla, C Alonso, W Amara, D Annane, C Antoine, P Aubry, E Azoulay, D Benhamou, C Billon, J Boutet, C Bruel, P Bruneval, P Carli, E Casalino, C Cerf, A Chaib, B Cholley, Y Cohen, A Combes, JM Coulaud, M Crahes, D Da Silva, V Das, A Demoule, I Denjoy, C Derkenne, N Deye, G Dhonneur, JL Diehl, S Dinanian, L Domanski, D Dreyfuss, D Duboc, JL Dubois-Rande, JP Empana, F Extramiana, M Fartoukh, F Fieux, B Frattini, M Gabbas, E Gandjbakhch, G Geri, B Guidet, F Halimi, P Henry, F Hidden-Lucet, P Jabre, L Jacob, L Joseph, D Journois, J Lacotte, K Lahlou-Laforet, A Lanceleur, O Langeron, T Lavergne, A Leenhardt, N Lellouche, V Lemiale, F Lemoine, F Linval, B Ludes, A Maltret, N Mansencal, N Mansouri, J Marty, E Maury, V Maxime, B Megarbane, A Mekontso-Dessap, JP Mira, X Monnet, N Ngoyi, MC Perier, O Piot, P Plaisance, I Plu, B Prunet, M Raux, F Revaux, JD Ricard, C Richard, F Roussin, F Santoli, F Schortgen, A Sharifzadehgan, JL Teboul, JF Timsit, P Tuppin, C Ursat, A Vieillard-Baron, S Voicu, K Wahbi, V Waldmann
Publikováno v:
Circulation: Cardiovascular Interventions
Circulation: Cardiovascular Interventions, 2020, 13 (9), pp.e009181. ⟨10.1161/CIRCINTERVENTIONS.119.009181⟩
Circulation: Cardiovascular Interventions, 2020, 13 (9), pp.e009181. ⟨10.1161/CIRCINTERVENTIONS.119.009181⟩
Background: Conflicting data exist regarding the benefit of urgent coronary angiogram and percutaneous coronary intervention (PCI) after sudden cardiac arrest, particularly in the absence of ST-segment elevation. We hypothesized that the type of lesi
Autor:
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P Abraham, Ahmad Masri, Pablo Garcia-Pavia, Sara Saberi, Neal K Lakdawala, Matthew T Wheeler, Anjali Owens, Milos Kubanek, Wojciech Wojakowski, Morten K Jensen, Juan Gimeno-Blanes, Kia Afshar, Jonathan Myers, Sheila M Hegde, Scott D Solomon, Amy J Sehnert, David Zhang, Wanying Li, Mondira Bhattacharya, Jay M Edelberg, Cynthia Burstein Waldman, Steven J Lester, Andrew Wang, Carolyn Y Ho, Daniel Jacoby, Jozef Bartunek, Antoine Bondue, Emeline Van Craenenbroeck, David Zemanek, Morten Jensen, Jens Mogensen, Jens Jakob Thune, Philippe Charron, Albert Hagege, Olivier Lairez, Jean-Noël Trochu, Christoph Axthelm, Hans-Dirk Duengen, Norbert Frey, Veselin Mitrovic, Michael Preusch, Jeanette Schulz-Menger, Tim Seidler, Michael Arad, Majdi Halabi, Amos Katz, Daniel Monakier, Offir Paz, Samuel Viskin, Donna Zwas, Hans Peter Brunner-La Rocca, Michelle Michels, Dariusz Dudek, Zofia Oko-Sarnowska, Nuno Cardim, Helder Pereira, Pablo García Pavia, Juan Gimeno Blanes, Rafael Hidalgo Urbano, Luis Miguel Rincón Diaz, Perry Elliott, Zaheer Yousef, Theodore Abraham, Paulino Alvarez, Richard Bach, Richard Becker, Lubna Choudhury, David Fermin, John Jefferies, Christopher Kramer, Neal Lakdawala, Steven Lester, Ali Marian, Mathew Maurer, Sherif Nagueh, David Owens, Florian Rader, Mark Sherrid, Jamshid Shirani, John Symanski, Aslan Turer, Omar Wever-Pinzon, Matthew Wheeler, Timothy Wong, Mohamad Yamani
Publikováno v:
DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
The Lancet
The Lancet, Elsevier, 2020, 396 (10253), pp.759-769. ⟨10.1016/S0140-6736(20)31792-X⟩
Lancet, 396(10253), 759-769. Elsevier Science
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Olivotto, I, Oreziak, A, Barriales-Villa, R, Abraham, T P, Masri, A, García Pavia, P, Saberi, S, Lakdawala, N K, Wheeler, M T, Owens, A, Kubanek, M, Wojakowski, W, Jensen, M K, Gimeno-Blanes, J, Afshar, K, Myers, J, Hegde, S M, Solomon, S D, Sehnert, A J, Zhang, D, Li, W, Bhattacharya, M, Edelberg, J M, Waldman, C B, Lester, S J, Wang, A, Ho, C Y, Jacoby, D & EXPLORER-HCM 2020, ' Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM) : a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet, vol. 396, no. 10253, pp. 759-769 . https://doi.org/10.1016/S0140-6736(20)31792-X
Universidad Francisco de Vitoria
The Lancet
The Lancet, Elsevier, 2020, 396 (10253), pp.759-769. ⟨10.1016/S0140-6736(20)31792-X⟩
Lancet, 396(10253), 759-769. Elsevier Science
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname
Olivotto, I, Oreziak, A, Barriales-Villa, R, Abraham, T P, Masri, A, García Pavia, P, Saberi, S, Lakdawala, N K, Wheeler, M T, Owens, A, Kubanek, M, Wojakowski, W, Jensen, M K, Gimeno-Blanes, J, Afshar, K, Myers, J, Hegde, S M, Solomon, S D, Sehnert, A J, Zhang, D, Li, W, Bhattacharya, M, Edelberg, J M, Waldman, C B, Lester, S J, Wang, A, Ho, C Y, Jacoby, D & EXPLORER-HCM 2020, ' Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM) : a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet, vol. 396, no. 10253, pp. 759-769 . https://doi.org/10.1016/S0140-6736(20)31792-X
Background: Cardiac muscle hypercontractility is a key pathophysiological abnormality in hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow tract (LVOT) obstruction. Available pharmacological options for hypertro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7751fccc2de1b5093dee54ed23cc2cd
http://hdl.handle.net/10641/2370
http://hdl.handle.net/10641/2370
Autor:
Svetlana Kozhevnikova, Albert HAGEGE, Roopen Arya, Paulus Kirchhof, Tiago Gregorio, Meyer ELBAZ, Aleksandr Rychkov, Gunnar Gislason, Michal Bar, Roman Batalov, Niall Mahon, Irina Kisteneva, Natalia Khorkova, Sergey Popov
Publikováno v:
European Heart Journal. 37:1145-1153
Aims Although non-vitamin K antagonist oral anticoagulants are recommended for stroke prevention in patients with non-valvular atrial fibrillation (NVAF) based on clinical trial results, there is a need for safety and efficacy data from unselected pa
Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
Autor:
Manuel Gómez-Bueno, Pascal De Groote, Albert HAGEGE, Aldo Pietro Maggioni, Laila Hübbert, Tchavdar Shalganov, Michel GALINIER, Katarzyna Mizia-Stec, Dirk Westermann, Burkert Pieske, Jiří Knot, Michael Zile, Piotr Ponikowski, John Atherton, Vojtech Melenovsky
Publikováno v:
Pieske, B, Butler, J, Filippatos, G, Lam, C, Maggioni, A P, Ponikowski, P, Shah, S, Solomon, S, Kraigher-Krainer, E, Samano, E T, Scalise, A V, Müller, K, Roessig, L, Gheorghiade, M & SOCRATES Investigators and Coordinators 2014, ' Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES) ', European Journal of Heart Failure, vol. 16, no. 9, pp. 1026-38 . https://doi.org/10.1002/ejhf.135
Aims The clinical outcomes for patients with worsening chronic heart failure (WCHF) remain exceedingly poor despite contemporary evidence-based therapies, and effective therapies are urgently needed. Accumulating evidence supports augmentation of cyc
Autor:
Albert HAGEGE
Publikováno v:
EMC - Traité de médecine AKOS. 8:1-7